Comparative efficacy of open endarterectomy versus endovascular treatments in common femoral artery stenocclusive disease: A Bayesian hierarchical meta‐analysis
Restricted accessReview articleFirst published online 2026
Comparative efficacy of open endarterectomy versus endovascular treatments in common femoral artery stenocclusive disease: A Bayesian hierarchical meta‐analysis
The management of Common Femoral Artery (CFA) stenocclusive disease presents unique challenges, with debates persisting regarding the optimal treatment strategy between Open Common Femoral Endarterectomy (CFE) and Endovascular Therapy (EVT). This study aimed to compare the efficacy of CFE versus EVT, as well as simple versus advanced EVT (aEVT), using a Bayesian hierarchical framework.
Methods
A systematic review was conducted according to PRISMA guidelines by querying PubMed, ScienceDirect, Scopus, and the Cochrane Library for articles published through June 2024. The study included randomized controlled trials and retrospective observational studies with a minimum of 40 patients per cohort. Data were synthesized using a Bayesian random-intercept logistic model to estimate pooled Odds Ratios (OR) for primary patency, freedom from reintervention, and limb salvage.
Results
The analysis included 10 comparative studies encompassing 1452 patients. Open CFE demonstrated superior outcomes compared to EVT, with a significantly reduced odds of patency loss (OR 0.480; 95% CrI: 0.367–0.626) and lower reintervention rates (OR 0.534; 95% CrI: 0.391–0.718). Limb salvage rates also favored CFE (OR 0.548; 95% CrI: 0.402–0.737). In subgroup analyses, advanced EVT (involving atherectomy) improved primary patency compared to simple EVT (OR 0.520; 95% CrI: 0.306–0.883) but did not statistically significantly reduce the need for reintervention (OR 0.910; 95% CrI: 0.427–1.894).
Conclusion
Open CFE remains the gold standard for CFA stenocclusive disease, offering superior long-term durability and limb salvage compared to endovascular interventions. While advanced endovascular techniques improve patency rates compared to simple balloon angioplasty, they fail to significantly reduce reintervention rates, likely due to the biomechanical stress of the femoral region. EVT should be considered a pragmatic option reserved primarily for high-surgical-risk patients.
FowkesFGRudanDRudanI, et al.Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet2013; 382(9901): 1329–1340. https://doi.org/10.1016/S0140-6736(13)61249-0, Epub 2013 Aug 1. PMID: 23915883.
2.
RutherfordRBBakerJDErnstC, et al.Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg1997; 26(3): 517–538. https://doi.org/10.1016/s0741-5214(97)70045-4, Erratum in: J Vasc Surg 2001 Apr;33(4):805. PMID: 9308598.
3.
AboyansVRiccoJBBartelinkMEL, et al.2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J2018; 39(9): 763–816. https://doi.org/10.1093/eurheartj/ehx095. PMID: 28886620.
4.
National Institute for Health and Care Excellence (NICE). Peripheral arterial disease: diagnosis and management (NICE guideline NG19). 2020.
5.
BoufiMEjargueMGayeM, et al.Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment. J Vasc Surg2021; 73(4): 1445–1455. https://doi.org/10.1016/j.jvs.2020.10.026, Epub 2020 Oct 22. PMID: 33098944.
6.
JiaXSunZDPatelJV, et al.Systematic review of endovascular intervention and surgery for common femoral artery atherosclerotic disease. Br J Surg2019; 106(1): 13–22. https://doi.org/10.1002/bjs.11026. PMID: 30582635.
7.
LinniKUgurluogluAHitzlW, et al.Bioabsorbable stent implantation vs. common femoral artery endarterectomy: early results of a randomized trial. J Endovasc Ther2014; 21(4): 493–502. https://doi.org/10.1583/14-4699R.1, PMID: 25101576.
8.
KuoTTChenPLHuangCY, et al.Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease. J Vasc Surg2019; 69(1): 141–147. https://doi.org/10.1016/j.jvs.2018.05.225, Epub 2018 Aug 10. PMID: 30104098.
9.
WiekerCMSchönefeldEOsadaN, et al.Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era. J Vasc Surg2016; 64(4): 995–1001. https://doi.org/10.1016/j.jvs.2016.04.036, PMID: 27666444.
10.
BallottaEGruppoMMazzalaiF, et al.Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery2010; 147(2): 268–274. https://doi.org/10.1016/j.surg.2009.08.004, Epub 2009 Oct 13. PMID: 19828166.
11.
MehtaMZhouYPatyPS, et al.Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting. J Vasc Surg2016; 64(2): 369–379. https://doi.org/10.1016/j.jvs.2016.03.418, PMID: 27763265.
12.
HalpinDErbenYJayasuriyaS, et al.Management of isolated atherosclerotic stenosis of the common femoral artery: a review of the literature. Vasc Endovasc Surg2017; 51(4): 220–227. https://doi.org/10.1177/1538574417702773, Epub 2017 Apr 4. PMID: 28376704.
13.
SiracuseJJVan OrdenKKalishJA, et al.Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg2017; 65(4): 1039–1046. https://doi.org/10.1016/j.jvs.2016.10.078, Epub 2016 Dec 29. PMID: 28041804.
14.
NishibeTMarunoKIwahoriA, et al.The role of common femoral artery endarterectomy in the endovascular era. Ann Vasc Surg2015; 29(8): 1501–1507. https://doi.org/10.1016/j.avsg.2015.05.005, Epub 2015 Jul 4. PMID: 26148640.
ZhangJKoCWNieL, et al.Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies. Stat Methods Med Res2019; 28(5): 1293–1310. https://doi.org/10.1177/0962280218754928, Epub 2018 Feb 13. PMID: 29433407; PMCID: PMC6719559.
17.
SpiegelhalterDJBestNGCarlinBP, et al.Bayesian measures of model complexity and fit. J Roy Stat Soc B2002; 64: 583–639. https://doi.org/10.1111/1467-9868.00353
18.
GouëfficYDella SchiavaNThaveauF, et al.Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv2017; 10(13): 1344–1354. https://doi.org/10.1016/j.jcin.2017.03.046, PMID: 28683941.
19.
StavroulakisKSchwindtATorselloG, et al.Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease. J Endovasc Ther2018; 25(1): 92–99. https://doi.org/10.1177/1526602817748319, Epub 2017 Dec 18. PMID: 29251204.
20.
ElsherifMTawfickWElsharkawiM, et al.Common femoral artery endarterectomy in the age of endovascular therapy. Vascular2018; 26(6): 581–590. https://doi.org/10.1177/1708538118772682, Epub 2018 May 14. PMID: 29759039.
21.
GuoJGuoLTongZ, et al.Directional atherectomy is associated with better long-term efficiency compared with angioplasty for common femoral artery occlusive disease in rutherford 2-4 patients. Ann Vasc Surg2018; 51: 65–71. https://doi.org/10.1016/j.avsg.2017.12.004, Epub 2018 Mar 1. PMID: 29501593.
22.
ImranHMHyderONSoukasPA. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease. Cardiovasc Revascularization Med2019; 20(3): 210–214. https://doi.org/10.1016/j.carrev.2018.06.018, Epub 2018 Jun 25. PMID: 29970328.
23.
KapetaniosDTorselloGTsilimparisN, et al.Directional atherectomy with antirestenotic therapy versus open repair in patients with restenotic disease after surgical revascularization of the common femoral artery. J Cardiovasc Surg2024; 65(4): 339–345. https://doi.org/10.23736/S0021-9509.24.13126-6, Epub 2024 Jul 15. PMID: 39008277.
24.
NakamaTTakaharaMIwataY, et al.CAULIFLOWER study investigators. 1-Year outcomes of thromboendarterectomy vs endovascular therapy for common femoral artery lesions: CAULIFLOWER study results. JACC Cardiovasc Interv2022; 15(14): 1453–1463. https://doi.org/10.1016/j.jcin.2022.03.010, Epub 2022 Jun 29. PMID: 35863795.
25.
WangZMurrayTAXiaoM, et al.Bayesian hierarchical models incorporating study-level covariates for multivariate meta-analysis of diagnostic tests without a gold standard with application to COVID-19. Stat Med2023; 42(28): 5085–5099. https://doi.org/10.1002/sim.9902, Epub 2023 Sep 19. PMID: 37724773.
26.
BonviniRFRastanASixtS, et al.Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol2011; 58(8): 792–798. https://doi.org/10.1016/j.jacc.2011.01.070, PMID: 21835313.
27.
SogaYTomoiYSatoK, et al.Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease. Cardiovasc Interv Ther2013; 28(3): 250–257. https://doi.org/10.1007/s12928-013-0164-1, Epub 2013 Jan 30. PMID: 23361951.
28.
MalgorRDRicottaJJ2ndBowerTC, et al.Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization. Ann Vasc Surg2012; 26(7): 946–956. https://doi.org/10.1016/j.avsg.2012.02.014, PMID: 22944568.
29.
HongSJKoYGSuhY, et al.Outcomes of stents covering the deep femoral artery origin. EuroIntervention2014; 10(5): 632–639. https://doi.org/10.4244/EIJV10I5A109, PMID: 25256202.
30.
KumaSTanakaKOhmineT, et al.Clinical outcome of surgical endarterectomy for common femoral artery occlusive disease. Circ J2016; 80(4): 964–969. https://doi.org/10.1253/circj.CJ-15-1177, Epub 2016 Feb 19. PMID: 26902450.
31.
BanerjeeSJeon-SlaughterHArmstrongEJ, et al.Clinical outcomes and cost comparisons of stent and non-stent interventions in infrainguinal peripheral artery disease: insights from the excellence in peripheral artery disease (XLPAD) registry. J Invasive Cardiol2019; 31(1): 1–9. https://doi.org/10.25270/jic/18.00285, PMID: 30611122; PMCID: PMC6428413.
32.
PiazzaMRicottaJJ2ndBowerTC, et al.Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease. J Vasc Surg2011; 54(2): 402–411. https://doi.org/10.1016/j.jvs.2011.01.027, Epub 2011 Apr 30. PMID: 21531527.
33.
BonviniRFRastanASixtS, et al.Angioplasty and provisional stent treatment of common femoral artery lesions. J Vasc Intervent Radiol2013; 24(2): 175–183. https://doi.org/10.1016/j.jvir.2012.10.020, Epub 2013 Jan 28. PMID: 23369554.
34.
AzémaLDavaineJMGuyomarchB, et al.Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg2011; 41(6): 787–793. https://doi.org/10.1016/j.ejvs.2011.02.025, Epub 2011 Mar 24. PMID: 21439857.
